Skip to main content
Erschienen in: Clinical Rheumatology 5/2005

01.10.2005 | Case Report

Idiopathic portal hypertension associated with systemic sclerosis and Sjögren’s syndrome

verfasst von: Hiroyuki Kogawa, Kiyoshi Migita, Masahiro Ito, Yasushi Takii, Manabu Daikoku, Mikiko Nakao, Taichiro Miyashita, Hironori Kimura, Hironori Ezaki, Minoru Nakamura, Hiroshi Yatsuhashi, Katsumi Eguchi, Hiromi Ishibashi

Erschienen in: Clinical Rheumatology | Ausgabe 5/2005

Einloggen, um Zugang zu erhalten

Abstract

We report a patient with idiopathic portal hypertension (IPH) associated with systemic sclerosis (SSc) and Sjögren’s syndrome. A 72-year-old Japanese woman was admitted to our hospital because of Raynaud’s phenomenon, sclerodactyly, and dyspnea. The patient had splenomegaly, esophageal varices in the absence of extrahepatic portal obstruction, and cirrhosis of the liver. Immunological studies revealed positive anti-nuclear antibodies and high titers of anti-Scl-70, anti-SS-A, anti-centromere, and anti-mitochondrial M2 antibodies. Histological examinations of the liver biopsy specimen revealed stenosis and loss of small portal veins without findings of primary biliary cirrhosis. The patient was diagnosed as having IPH associated with SSc and Sjögren’s syndrome. These observations suggest an immunological role in the pathogenesis of IPH.
Literatur
1.
Zurück zum Zitat Boyer JL, Sen Gupta KP, Biswas SK, Pal NC, Basu Mallick KC, Iber FL, Basu AK (1967) Idiopathic portal hypertension. Comparison with the portal hypertension of cirrhosis and extrahepatic portal vein obstruction. Ann Intern Med 66:41–68PubMed Boyer JL, Sen Gupta KP, Biswas SK, Pal NC, Basu Mallick KC, Iber FL, Basu AK (1967) Idiopathic portal hypertension. Comparison with the portal hypertension of cirrhosis and extrahepatic portal vein obstruction. Ann Intern Med 66:41–68PubMed
2.
Zurück zum Zitat Okudaira M, Ohbu M, Okuda K (2002) Idiopathic portal hypertension and its pathology. Semin Liver Dis 22:59–72CrossRefPubMed Okudaira M, Ohbu M, Okuda K (2002) Idiopathic portal hypertension and its pathology. Semin Liver Dis 22:59–72CrossRefPubMed
3.
Zurück zum Zitat Okuda K, Kono K, Ohnishi K, Kimura K, Omata M, Koen H, Nakajima Y, Musha H, Hirashima T, Takashi M (1984) Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology 86:600–610PubMed Okuda K, Kono K, Ohnishi K, Kimura K, Omata M, Koen H, Nakajima Y, Musha H, Hirashima T, Takashi M (1984) Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology 86:600–610PubMed
4.
Zurück zum Zitat Inagaki H, Nonami T, Kawagoe T, Miwa T, Hosono J, Kurokawa T, Harada A, Nakao A, Takagi H, Suzuki H, Sakamoto J (2000) Idiopathic portal hypertension associated with systemic lupus erythematosus. J Gastroenterol 35:235–239CrossRefPubMed Inagaki H, Nonami T, Kawagoe T, Miwa T, Hosono J, Kurokawa T, Harada A, Nakao A, Takagi H, Suzuki H, Sakamoto J (2000) Idiopathic portal hypertension associated with systemic lupus erythematosus. J Gastroenterol 35:235–239CrossRefPubMed
5.
Zurück zum Zitat Hirasaki S, Koide N, Ogawa H, Wada T, Sato A, Ujike K, Tsuji T (1997) Mixed connective tissue disease associated with idiopathic portal hypertension and chronic thyroiditis. J Gastroenterol 32:808–811PubMed Hirasaki S, Koide N, Ogawa H, Wada T, Sato A, Ujike K, Tsuji T (1997) Mixed connective tissue disease associated with idiopathic portal hypertension and chronic thyroiditis. J Gastroenterol 32:808–811PubMed
6.
Zurück zum Zitat Terada T, Hoso M, Nakanuma Y (1989) Microvasculature in the small portal tracts in idiopathic portal hypertension. A morphological comparison with other hepatic diseases. Virchows Arch A Pathol Anat Histopathol 415:61–67CrossRefPubMed Terada T, Hoso M, Nakanuma Y (1989) Microvasculature in the small portal tracts in idiopathic portal hypertension. A morphological comparison with other hepatic diseases. Virchows Arch A Pathol Anat Histopathol 415:61–67CrossRefPubMed
7.
Zurück zum Zitat Nakanuma Y, Nonomura A, Hayashi M, Doishita K, Takayanagi N, Uchida T, Obata Y, Noma K, Ikoma J, Yoshikawa K (1989) Pathology of the liver in “idiopathic portal hypertension” associated with autoimmune disease. The Ministry of Health and Welfare Disorders of Portal Circulation Research Committee. Acta Pathol Jpn 39:586–592PubMed Nakanuma Y, Nonomura A, Hayashi M, Doishita K, Takayanagi N, Uchida T, Obata Y, Noma K, Ikoma J, Yoshikawa K (1989) Pathology of the liver in “idiopathic portal hypertension” associated with autoimmune disease. The Ministry of Health and Welfare Disorders of Portal Circulation Research Committee. Acta Pathol Jpn 39:586–592PubMed
8.
Zurück zum Zitat Saito K, Nakanuma Y, Takegoshi K, Ohta G, Obata Y, Okuda K, Kameda H (1993) Non-specific immunological abnormalities and association of autoimmune diseases in idiopathic portal hypertension. A study by questionnaire. Hepatogastroenterology 40:163–166PubMed Saito K, Nakanuma Y, Takegoshi K, Ohta G, Obata Y, Okuda K, Kameda H (1993) Non-specific immunological abnormalities and association of autoimmune diseases in idiopathic portal hypertension. A study by questionnaire. Hepatogastroenterology 40:163–166PubMed
9.
Zurück zum Zitat Morris JS, Htut T, Read AE (1972) Scleroderma and portal hypertension. Ann Rheum Dis 31:316–318PubMed Morris JS, Htut T, Read AE (1972) Scleroderma and portal hypertension. Ann Rheum Dis 31:316–318PubMed
10.
Zurück zum Zitat Umeyama K, Yui S, Fukamizu A, Yoshikawa K, Yamashita T (1982) Idiopathic portal hypertension associated with progressive systemic sclerosis. Am J Gastroenterol 77:645–648PubMed Umeyama K, Yui S, Fukamizu A, Yoshikawa K, Yamashita T (1982) Idiopathic portal hypertension associated with progressive systemic sclerosis. Am J Gastroenterol 77:645–648PubMed
11.
Zurück zum Zitat Tsuneyama K, Harada K, Katayanagi K, Watanabe K, Kurumaya H, Minato H, Nakanuma Y (2002) Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a review of literature. J Gastroenterol Hepatol 17:217–223CrossRefPubMed Tsuneyama K, Harada K, Katayanagi K, Watanabe K, Kurumaya H, Minato H, Nakanuma Y (2002) Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a review of literature. J Gastroenterol Hepatol 17:217–223CrossRefPubMed
12.
Zurück zum Zitat Kitamura Y, Tsukada N, Atsukawa K, Shinagawa J, Yonei Y, Inagaki Y, Miyamoto K, Suzuki O, Kawamura Y, Kiryu Y (1995) A case of non-cirrhotic portal hypertension complicated with Sjögren’s syndrome and thrombocytosis. Nippon Shokakibyo Gakkai Zasshi 92:95–100PubMed Kitamura Y, Tsukada N, Atsukawa K, Shinagawa J, Yonei Y, Inagaki Y, Miyamoto K, Suzuki O, Kawamura Y, Kiryu Y (1995) A case of non-cirrhotic portal hypertension complicated with Sjögren’s syndrome and thrombocytosis. Nippon Shokakibyo Gakkai Zasshi 92:95–100PubMed
13.
Zurück zum Zitat Tan PL, Wigley RD, Borman GB (1981) Clinical criteria for systemic sclerosis. Arthritis Rheum 24:1589–1590PubMed Tan PL, Wigley RD, Borman GB (1981) Clinical criteria for systemic sclerosis. Arthritis Rheum 24:1589–1590PubMed
14.
Zurück zum Zitat Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S (1993) Preliminary criteria for the classification of Sjögren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36:340–347PubMed Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S (1993) Preliminary criteria for the classification of Sjögren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36:340–347PubMed
15.
Zurück zum Zitat Reimer G (1990) Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma). Rheum Dis Clin North Am 16:169–183PubMed Reimer G (1990) Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma). Rheum Dis Clin North Am 16:169–183PubMed
16.
Zurück zum Zitat Kajiura K, Fujiki K, Yamada M, Takenaga T, Takashimizu I, Tamura Y, Yamamoto N, Sasabe M, Fujimoto H, Nakamura R (1990) A case of idiopathic portal hypertension (IPH) with positive anti mitochondrial antibody. Nippon Shokakibyo Gakkai Zasshi 87:1243–1247PubMed Kajiura K, Fujiki K, Yamada M, Takenaga T, Takashimizu I, Tamura Y, Yamamoto N, Sasabe M, Fujimoto H, Nakamura R (1990) A case of idiopathic portal hypertension (IPH) with positive anti mitochondrial antibody. Nippon Shokakibyo Gakkai Zasshi 87:1243–1247PubMed
17.
Zurück zum Zitat Derk CT, Jimenez SA (2003) Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev 2:181–191CrossRefPubMed Derk CT, Jimenez SA (2003) Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev 2:181–191CrossRefPubMed
18.
Zurück zum Zitat Sawai T, Tutikawa K, Watanabe T, Kyogoku M (1988) A case of mixed connective tissue disease (MCTD) complicating pulmonary hypertension and portal hypertension. Ryumachi 28:164–169PubMed Sawai T, Tutikawa K, Watanabe T, Kyogoku M (1988) A case of mixed connective tissue disease (MCTD) complicating pulmonary hypertension and portal hypertension. Ryumachi 28:164–169PubMed
Metadaten
Titel
Idiopathic portal hypertension associated with systemic sclerosis and Sjögren’s syndrome
verfasst von
Hiroyuki Kogawa
Kiyoshi Migita
Masahiro Ito
Yasushi Takii
Manabu Daikoku
Mikiko Nakao
Taichiro Miyashita
Hironori Kimura
Hironori Ezaki
Minoru Nakamura
Hiroshi Yatsuhashi
Katsumi Eguchi
Hiromi Ishibashi
Publikationsdatum
01.10.2005
Erschienen in
Clinical Rheumatology / Ausgabe 5/2005
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-1084-y

Weitere Artikel der Ausgabe 5/2005

Clinical Rheumatology 5/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.